Outlook Therapeutics, Inc.
(NASDAQ : OTLK)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -4.90%58.570.0%$906.01m
AMGNAmgen, Inc. 1.22%258.241.3%$750.82m
GILDGilead Sciences, Inc. 0.38%76.351.0%$724.94m
REGNRegeneron Pharmaceuticals, Inc. 2.18%622.452.5%$659.43m
NVAXNovavax, Inc. 2.43%81.64102.0%$580.82m
BIIBBiogen, Inc. 0.13%265.121.6%$559.05m
VRTXVertex Pharmaceuticals, Inc. 1.68%291.101.9%$527.74m
ILMNIllumina, Inc. 1.24%373.103.5%$308.62m
ALXNAlexion Pharmaceuticals, Inc. -0.08%112.302.0%$228.46m
BMRNBioMarin Pharmaceutical, Inc. 0.75%126.784.3%$214.78m
SGENSeattle Genetics, Inc. 0.90%169.036.1%$202.30m
SRNESorrento Therapeutics, Inc. -1.15%6.851.8%$184.40m
SRPTSarepta Therapeutics, Inc. -1.77%162.7513.9%$167.23m
INCYIncyte Corp. 3.72%106.472.5%$163.35m
IMMUImmunomedics, Inc. 1.71%37.5411.0%$159.56m

Company Profile

Outlook Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the identification, development, manufacture, and commercialization of complex biosimilar therapeutics. It focuses on monoclonal antibodies, in the disease areas of immunology and oncology. The company was founded by Pankaj Mohan on January 5, 2010 and is headquartered in Cranbury, NJ.